Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China · Delayed Price · Currency is CNY 21.80
+0.05 (0.23%)
At close: Aug 4, 2026
SHA:688161 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,641 | 11,092 | 10,020 | 16,580 | 20,876 | 25,488 | |
Market Cap Growth | -26.50% | 10.71% | -39.57% | -20.58% | -18.09% | - |
Enterprise Value | 7,026 | 9,274 | 8,039 | 14,778 | 18,239 | 22,115 |
Last Close Price | 21.75 | 27.60 | 24.69 | 40.15 | 50.11 | 60.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.48 | 41.29 | 44.78 | 147.62 | 34.75 | 36.92 |
Forward PE | 27.19 | 36.74 | 36.82 | 23.16 | 21.46 | 28.51 |
PS Ratio | 5.65 | 7.28 | 6.90 | 12.92 | 10.14 | 11.84 |
PB Ratio | 2.04 | 2.67 | 2.53 | 4.28 | 4.17 | 5.62 |
P/TBV Ratio | 2.18 | 2.76 | 2.62 | 4.46 | 4.26 | 5.75 |
P/FCF Ratio | 23.60 | 28.56 | 40.10 | 216.83 | 53.15 | 37.71 |
P/OCF Ratio | 21.78 | 26.70 | 36.54 | 138.81 | 41.05 | 32.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.60 | 6.09 | 5.53 | 11.51 | 8.86 | 10.27 |
EV/EBITDA Ratio | 21.82 | 28.61 | 29.03 | 122.92 | 26.93 | 27.24 |
EV/EBIT Ratio | 26.59 | 33.90 | 37.12 | 237.16 | 29.40 | 29.08 |
EV/FCF Ratio | 19.19 | 23.88 | 32.17 | 193.26 | 46.43 | 32.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.04 | 0.05 | 0.02 | 0.08 | 0.02 | 0.02 |
Debt / FCF Ratio | 0.04 | 0.05 | 0.03 | 0.14 | 0.04 | 0.03 |
Net Debt / Equity Ratio | -0.39 | -0.79 | -0.79 | -0.79 | -0.78 | -0.80 |
Net Debt / EBITDA Ratio | -5.28 | -10.11 | -11.32 | -25.53 | -5.75 | -4.49 |
Net Debt / FCF Ratio | -4.50 | -8.44 | -12.54 | -40.14 | -9.92 | -5.39 |
Asset Turnover | 0.30 | 0.30 | 0.29 | 0.23 | 0.36 | 0.50 |
Inventory Turnover | 0.89 | 0.89 | 0.75 | 0.65 | 0.80 | 0.73 |
Quick Ratio | 2.23 | 4.23 | 4.02 | 3.17 | 5.10 | 5.57 |
Current Ratio | 4.76 | 4.99 | 4.88 | 3.92 | 5.91 | 6.41 |
Return on Equity (ROE) | 6.42% | 6.74% | 5.83% | 2.55% | 12.58% | 19.75% |
Return on Assets (ROA) | 3.25% | 3.42% | 2.70% | 0.70% | 6.79% | 11.08% |
Return on Invested Capital (ROIC) | 13.11% | 26.98% | 22.32% | 5.60% | 52.67% | 73.87% |
Return on Capital Employed (ROCE) | 6.20% | 6.50% | 5.30% | 1.60% | 12.10% | 16.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.02% | 2.42% | 2.23% | 0.68% | 2.88% | 2.71% |
FCF Yield | 4.24% | 3.50% | 2.49% | 0.46% | 1.88% | 2.65% |
Dividend Yield | 1.56% | 1.23% | 1.18% | 0.30% | 0.82% | 0.86% |
Payout Ratio | 48.92% | 47.53% | 33.63% | 146.01% | 35.20% | - |
Buyback Yield / Dilution | 0.07% | -0.35% | 0.39% | -0.16% | -5.58% | -5.96% |
Total Shareholder Return | 1.65% | 0.88% | 1.57% | 0.14% | -4.76% | -5.10% |